Related Experiment Video
Updated: Apr 28, 2026

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity
Published on: November 2, 2020
Frequent activating HRAS mutations in trichilemmoma
J-H Tsai1, W-C Huang, J-Y Jhuang
1Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Pathology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Most trichilemmomas, benign skin tumors, are driven by HRAS gene mutations. These HRAS mutations, particularly c.37G>C, are common in both naevus sebaceus-related and sporadic cases, indicating they are true neoplasms.
Area of Science:
- Dermatopathology
- Oncology
- Molecular Biology
Background:
- Trichilemmoma is a benign tumor of follicular epithelium.
- Its association with Cowden syndrome and naevus sebaceus (NS) is known, but sporadic tumor pathogenesis is unclear.
- Recent findings link NS to HRAS or KRAS mutations.
Purpose of the Study:
- To investigate RAS gene mutations in trichilemmomas.
- To compare mutation status in NS-related versus NS-unrelated tumors.
Main Methods:
- Analysis of 12 NS-related and 15 NS-unrelated trichilemmomas.
- PCR and direct sequencing of HRAS, KRAS, and NRAS genes (exons 1-2).
- Analysis of FGFR3 and PIK3CA hotspots in sporadic cases.
Main Results:
- HRAS mutations (c.37G>C and c.182A>G) were found in 20 of 27 trichilemmomas.
- HRAS c.37G>C occurred in 11/12 NS-related and 6/15 sporadic tumors.
- HRAS c.182A>G occurred in 3/15 sporadic tumors, not in NS-related tumors.
Conclusions:
- The high frequency of HRAS mutations suggests trichilemmomas are true neoplasms.
- Specific HRAS mutations are prevalent in both associated and sporadic forms.
- The c.182A>G mutation is specific to sporadic trichilemmomas.
Related Concept Videos
The Ras Gene
Ras is a...
Abnormal Proliferation
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

